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Abstract
Background: Obesity and inflammation are highly integrated processes in the pathogenesis of insulin resistance,
diabetes, dyslipidemia, and non-alcoholic fatty liver disease. Molecular mechanisms underlying inflammatory events
during high fat diet-induced obesity are poorly defined in mouse models of obesity. This work investigated gene
activation signals integral to the temporal development of obesity.
Methods: Gene expression analysis in multiple organs from obese mice was done with Taqman Low Density Array
(TLDA) using a panel of 92 genes representing cell markers, cytokines, chemokines, metabolic, and activation
genes. Mice were monitored for systemic changes characteristic of the disease, including hyperinsulinemia, body
weight, and liver enzymes. Liver steatosis and fibrosis as well as cellular infiltrates in liver and adipose tissues were
analyzed by histology and immunohistochemistry.
Results: Obese C57BL/6 mice were fed with high fat and cholesterol diet (HFC) for 6, 16 and 26 weeks. Here we
report that the mRNA levels of macrophage and inflammation associated genes were strongly upregulated at
different time points in adipose tissues (6-16 weeks) and liver (16-26 weeks), after the start of HFC feeding. CD11b
+
and CD11c
+ macrophages highly infiltrated HFC liver at 16 and 26 weeks. We found clear evidence that signals for
IL-1b, IL1RN, TNF-a and TGFb-1 are present in both adipose and liver tissues and that these are linked to the
development of inflammation and insulin resistance in the HFC-fed mice.
Conclusions: Macrophage infiltration accompanied by severe inflammation and metabolic changes occurred in both
adipose and liver tissues with a temporal shift in these signals depending upon the duration of HFC feeding. The
evidences of gene expression profile, elevated serum alanine aminotransferase, and histological data support a progression
towards nonalcoholic fatty liver disease and steatohepatitis in these HFC-fed mice within the time frame of 26 weeks.
Background
Increased adiposity with the consequence of chronic low-
grade inflammation and insulin resistance or type 2 dia-
betes has been linked to the development of nonalcoholic
fatty liver disease (NAFLD). Currently, up to 30 percent
of the general population is affected by NAFLD with 35
to 50 percent of obese adults also being diagnosed with
nonalcoholic steatohepatitis (NASH). NAFLD has been
described as the emerging clinical problem for the obese
patient in the 21
st century [1]. The pathways that are
active in promoting this disease process in the liver both
in humans and in mouse models are poorly understood
and are an active area of research.
There are a number of observations in the literature
linking adiposity with inflammation and increased liver
disease. Adipose tissue from obese people contains an
increased number of CD68
+ macrophages with a pro-
inflammatory phenotype [2]. In insulin-resistant patients
with fatty liver disease, there is a significant upregulation
of genes involved in fatty acid partitioning and binding
proteins, monocyte recruitment and inflammation [3].
Obese mice demonstrate a significant increase in
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any medium, provided the original work is properly cited.plasminogen activator in the fatty liver [4]. Likewise, the
absence of CCR2 protects the liver against fat accumula-
tion in the diet-induced obese mouse [5].
In the attempt to model the human disease process in
rodents, researchers have used several versions of the
Western diet and have found differences in severity of dis-
ease and times of disease onset depending upon the type
of fats used for feeding. Mice fed diets high in trans fats
combined with high fructose in the drinking water develop
very aggressive liver disease within two months whereas
mice fed only 20% of calories from high fat develop liver
disease in nine months [6,7]. The genetic background of
the rodent (C57BL/6 versus DBA/2) as well as cholesterol
content of the diet and even the presence of endotoxin has
been documented to strongly influence the development
pattern of liver disease [8,9]. Zheng et al. [10] in our insti-
tution use a rodent model which incorporates a 45% fat
diet with 0.12% cholesterol to reflect approximate percen-
tages found in the Western diet. This rodent model has all
the hallmarks of obesity, insulin resistance, and liver stea-
tosis plus it offers the further advantage of proven use for
the investigation of therapeutic drugs relevant to these dis-
eases, such as ezetimibe [10].
As a prelude to the use of the model in other drug stu-
dies, we attempted to determine the molecular pathways
that were activated in this mouse model of high fat and
cholesterol (HFC) feeding as the syndrome progressed
towards liver steatosis and fibrosis. We used a sensitive
a n dh i g ht h r o u g h p u tt e c h n ology, Taqman Low Density
Array (TLDA) to study message expression profiling of 92
genes representing macrophage-associated, inflammation-
related and metabolism-driven genes in various tissues,
including the adipose tissues and liver at 6 weeks, midway
at 16 weeks and at 26 weeks post-HFC feeding. We report
here that there is an initial upregulation of genes in the
epididymal adipose tissue that is accompanied by a rela-
tively quiescent liver profile at 6 weeks post-HFC followed
by a dramatic shift in emphasis away from the epididymal
adipose tissue to liver tissue gene activation at 16 weeks
and 26 weeks. Capturing changes in gene expression pro-
files from different organ systems as disease progression of
the liver is actively occurring will allow valuable informa-
tion on molecular mechanisms leading to NAFLD and
NASH to be gathered in animal models of obesity and will
lead to the identification of new therapeutic targets.
Methods
Animals and Diet
Six week old C57BL/6 male mice (Charles River Labora-
tories, Wilmington, MA) were housed in individual cages
and kept at a temperature of 22°C and maintained on a
12:12 h light/dark cycle. Three separate cohorts of mice
were used for these experiments so that evaluations could
be performed at 6 weeks, 16 weeks and 26 weeks post-high
fat feeding. Mice were fed a semi-purified diet containing
high fat and cholesterol (45% Kcal from lard/soybean oil;
20% Kcal from protein; 35% Kcal from carbohydrate and
0.12% cholesterol by weight obtained from Research Diets
(D0401280; New Brunswick, NJ) beginning at 7 weeks of
age. Separate cohorts of age-matched normal animals were
maintained on regular chow (Purina #5053) which provides
24.65% Kcal from protein; 62.14% Kcal from carbohydrate;
and 13.2% Kcal from fat. The mineral and vitamin compo-
nents were comparable between the two diets. C57BL/6
mice do not all gain weight on a uniform basis when fed
this high fat diet. In order to minimize variability in our
gene analysis results, mice were selected for their suscept-
ibility to diet-induced obesity at day 21 following the start
of high fat and cholesterol (HFC) feeding. Animals were
considered to be diet-obese (DIO) if there was a seven
gram body weight gain or greater after 21 days. In the
cohorts of 150 mice started for each of these experiments,
approximately 17% of mice fail this selection criterion on
day 21 and are eliminated from further study. Body weight
was followed throughout the course of the experiment.
Total body fat was determined by use of a whole body
magnetic resonance imager (EchoMR11200; Echo Medical
Systems, Houston, TX).
The blood samples for analysis of insulin and glucose
were taken from overnight-fasted animals in the morn-
ing at approximately 10 am. This measurement was
done about three days prior to termination of the group.
Glucose and insulin concentrations (in Table 1) are pre-
sented in International Units as mmol/l and pmol/l,
respectively. Homeostatic model assessment (HOMA)
values were calculated as an estimate of insulin sensitiv-
ity using the formula: fasting plasma glucose (mmol/l) ×
insulin (μU/ml) divided by 22.5. Higher values of
HOMA indicate the presence of reduced insulin sensi-
tivity in the animals [11]. The conversion of insulin
concentration from International Units is 1 μU/ml =
6 pmol/l. This conversion factor is stated in the SI units
table of the Journal of Diabetes Care.
Blood samples for lipid profile, cytokine analysis and
liver enzymes were taken on the day of termination
from non-fasted animals at approximately the same
time. All studies were carried out in our vivarium in
a c c o r d a n c ew i t ht h eG u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals of the National Institutes of Health
and the Animal Welfare Act under the supervision of
our institutional Animal Care and Use Committee.
Serum Cytokines and Other Mediators
Serum was evaluated for GM-CSF, insulin, leptin,
MCP-1, IL-6, TNF-a, IL-10, IL12p70, IL-1b,K C( M e s o
Scale Discovery, Gaithersburg, MD); serum amyloid A
(Life Diagnostics, West Chester, PA); alanine amino-
transferase (ALT) (Catachem, Bridgeport, CA) and
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from cytokine and mediator evaluation is reported as
the mean (sem) of the group. All statistical analysis was
performed by Mann-Whitney U test using GraphPad
Instat version 3.06 for Windows XP (GraphPad Soft-
ware, San Diego, CA).
Histology and immunohistochemistry (IHC)
5 μm paraffin sections were stained by either hematoxy-
lin and eosin (H&E) or Masson trichrome stain [12].
For IHC and oil red O staining, frozen liver or adipose
tissues embedded in OCT were cut at 5 (IHC) or 10 μm
(oil red O) and freshly frozen in -80°C freezer until use.
After fixation with acetone, tissue sections were incu-
bated with anti-CD11b (BD Bioscience), anti-CD11c
(Endogen), anti-IL-1b (R&D) or anti-F4/80 (Serotec) for
1 h at room temperature followed by incubation with
either biotinylated rabbit anti-rat or donkey anti-goat
antibodies. Selective binding was visualized by the enzy-
matic reaction of an alkaline phosphatase (ABC kit, Vec-
tor) with its substrate, permanent red (Dako).
Hematoxylin was used for counterstaining. Oil red O
staining was carried out as described [13].
RNA isolation and quantitative RT-PCR
Tissue collection and homogenization
Approximately 300-500 μl of blood from each mouse
was collected and added to a PAXgene blood RNA tube
containing ~1.3 ml of a proprietary reagent developed
by PreAnalytiX. Pancreas was isolated using a method
adapted from Mullin et al. [14]. Remaining tissues
(mesenteric lymph nodes, mesenteric fat pad, epididymal
fat pad, spleen, liver and gastrocnemius muscle) were
excised and flash frozen in liquid nitrogen.
A TissueLyser (Qiagen, Valencia, CA) was used to
homogenize and disrupt collected tissues in preparation
for total RNA extraction. A sterile 5 mm stainless steel
bead and 1 ml QIAzol lysis reagent (for epididymal and
mesenteric fat pads), 350 μl buffer RLT (for mesenteric
lymph nodes) or 2 ml buffer RLT (for liver, spleen and
gastrocnemius muscle) was added to each 2 ml eppen-
dorf tube containing the frozen tissue piece. Tissues were
then agitated at 30 Hz for 2 × 2 minutes as per the
recommendations of the Qiagen TissueLyser handbook.
A handheld TissueMiser (Thermo-Fisher Scientific) was
used to homogenize and disrupt the pancreas tissues.
RNA isolation and cDNA synthesis
Total RNA isolation from all tissues was performed
according to manufacturer’s protocol (Qiagen, Valencia,
CA). Optional on column DNase digestion was per-
formed on all tissues. Total RNA from blood was iso-
lated on the day it was collected using PAXgene Blood
RNA kit. All isolated total RNA was stored at -80°C
until further use. RNA was quantified using the Nano-
Drop
® ND-1000 spectrophotometer (Agilent Technolo-
gies, Santa Clara, CA). RNA quality was assessed by
Table 1 Assessment of serum metabolic parameters in diet-induced obese mice post-HFC initiation.
Parameter 6 weeks 16 weeks 26 weeks
HFC Chow fold
change
HFC Chow fold change HFC Chow fold change
Epididymal
fat pad, % 5.6 (0.8) 2.8 (0.1) 2.0 2.6 (0.2)* 3.8 (0.3) 0.7 2.4 (0.3)** 4.2 (0.4) 0.6
Mesenteric
fat pad, % 1.6 (0.1)* 0.9 (0.1) 1.8 2.1 (0.1) 1.6 (0.2) 1.3 1.9 (0.1) 1.9 (0.2) 1.0
Liver, % 3.6 (0.3) 3.7 (2) 1.0 7.3 (0.4)* 4.5 (0.4) 1.6 7.1 (0.4)* 4.6 (0.1) 1.5
ALT, U/ml 17 (2) 24 (3) 0.7 151 (24)* 31 (2) 4.9 76 (12)* 8 (1) 9.5
glucose, mmol/l 10.24 (0.25) 8.52 (0.25) 1.2 15.13 (0.54) 14.04 (0.46) 1.1 11.35 (0.28) 11.54 (0.34) 1.0
insulin, pmol/l 41.96 (2.81)* 28.85 (6.17) 1.5 436.49 (86.01)* 74.22 (9.97) 5.9 490.22 (55.19)* 278.26 (36.93) 1.8
HOMA 3.19 (0.24)* 1.92 (0.47) 1.7 47.83 (9.26)* 7.76 (1.14) 6.2 39.10 (3.35)* 24.12 (3.53) 1.6
adiponectin, μg/ml 6.7 (0.7) 6.0 (1) 1.1 12 (0.4)* 16 (0.8) 0.8 23 (3) 21 (2) 1.1
leptin, ng/ml 43 (10)* 0.5 (0.2) 86. 0 22 (6)* 4 (1) 5.5 46 (8)* 17 (3) 2.7
MCP-1, pg/ml 32 (2)* 26 (2) 1.2 36 (2)* 23 (2) 1.6 302 (26)* 134 (8) 2.3
IL-6, pg/ml 7 (1) 6 (1) 1.2 25 (6)* 12 (2) 2.1 33 (9)* 17 (5) 1.9
KC, pg/ml 32 (2) 21 (1) 1.5 67 (4) 44 (8) 1.5 98 (12)* 45 (4) 2.2
IL-10, pg/ml 15 (2) 27 (6) 0.6 124 (43) 47 (6) 2.6 45 (17)* 17 (6) 2.6
serum amyloid A
μg/ml 1.1 (0.02) 0.5 (0.2) 2.2 1.6 (0.7) 0.81 (0.05) 2.0 1.85 (0.2)* 0.43 (0.06) 4.3
Assessment was done at the termination point of 6, 16 or 26 weeks post-HFC initiation.
Values are means (sem), n = 14-20 per group. *confidence interval = 95%; **confidence interval = 99%.
The fold change is calculated as the level in HFC group divided by the level obtained from the Chow group.
The levels of GM-CSF, TNF-a, IL-12p70 and IL-1b were below detection limit of the assays.
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maldehyde gel. First strand cDNA synthesis was per-
formed using the Applied Biosystems High Capacity
cDNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA) according to manufacturer’si n s t r u c -
tions. To ensure equal loading of all samples on the
TLDA card, cDNA was quantified against an 18S stan-
dard curve prepared using human universal reference
total RNA purchased from Clontech (BD Biosciences
Clontech, Heidelberg, Germany).
Taqman Low Density Array
Quantitative real-time PCR utilized custom made Taq-
Man
® Low Density Array (TLDA) from Applied Biosys-
tems and followed the manufacturer’s instructions.
Thermal cycling was performed using an ABI Prism
7900HT Sequence Detection System. 100 ng cDNA in
100 μl of Applied Biosystems 1X Universal PCR Master
mix was loaded onto each port of the TLDA plates.
Data was analyzed using SDS v2.2 software. The Ct
value of each gene is normalized to 18S to obtain ΔCt.
Relative quantitation or fold changes in gene expression
were determined using the formula 2
-ΔΔCt,w h e r e
ΔΔCt = average ΔCt of all HFC-fed samples - average
ΔCt of all chow-fed samples. Statistical significance was
determined by two-tailed Welch t test using either
GraphPad Prism 4 or Microsoft Excel 2003, where P <
0.05 (*), P < 0.01 (**), and P < 0.001 (***). Unmarked
data points are not significant. The numbers of mice in
each group are as follows: 7 Chow-fed and 15 HFC-fed
mice at 6 weeks; 8 Chow-fed and 10 HFC-fed mice at
16 weeks; and 10 Chow-fed and 12 HFC-fed mice at 26
weeks.
Results
To qualify our animal model as described previously by
Zheng et al. [10] we have characterized the animals by
tracking their body weight changes and the levels of
serum mediators and cytokines throughout the time
course. The percent body weight increased progressively
in the HFC-fed mice over the 6 to 16 week study period
and was maximal at 26 weeks post-HFC (Figure 1A).
This body weight increase was accompanied by an
increase in fat mass (gms) determined by MRI (Figure
1B). There was no effect of diet treatment on lean body
mass. The HOMA index (Table 1) indicates that the
high fat fed mice developed a significant degree of insu-
lin resistance at the time points measured for this
experiment. The epididymal fat pad measured at 6
weeks was the organ most strikingly affected when com-
pared to the chow-fed animals. However, as the experi-
ment progressed to 16 and 26 weeks, the epididymal fat
pad weight as a percent of body weight actually
decreased (Table 1). The liver weight (expressed as a
percent of body weight) of the 6-week HFC-fed mice
was unchanged from chow-fed controls; however, the
liver weight of 16- and 26-week HFC-fed mice showed a
continuous increase relative to the chow-fed mice. This
increase in liver weight at 16 and 26 weeks was accom-
panied by an increase in the serum levels of alanine
aminotransferase (ALT), indicative of progressive liver
damage (Table 1).
We measured a variety of serum cytokines and media-
tors from these animals at the observation points. We
found that there was a large degree of variability in
these animals despite pre-selection for diet-induced obe-
sity (DIO). We routinely kept the animals on a HFC
diet for 3 weeks prior to entrance into the experimental
cohorts to ensure that all animals chosen had at least a
30% increase in body weight when compared to chow-
fed mice. Of the adipokines measured, serum leptin
(A)
(B)
Figure 1 P e r c e n tb o d yw e i g h tg a i na n df a tm a s si n c r e a s ei n
HFC-fed mice over time. A: Percent body weight gain over time.
All time points plotted are P < 0.01 for 45% high fat + 0.12%
cholesterol (HFC) vs. chow-diet (CHOW), Mann-Whitney U test.
Animals selected at day 21 for increased body weight (DIO; diet-
induced obesity). B: Body Density Parameters determined by MRI
Analysis. *P < 0.0001 for fat mass of HFC vs. CHOW, Mann-Whitney
U test.
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nectin decreased only at 16 weeks of HFC feeding. Of
the chemokines tested, MCP-1 (CCL2) was elevated
throughout the observation periods in the HFC-fed
mice; KC levels although higher than those of the chow-
fed mice were not significantly elevated until 26 weeks
post-HFC. Of the pro-inflammatory cytokines measured,
IL-6 showed a modest increase at 16 and 26 weeks
post-HFC. We did not obtain appreciable increases in
circulating levels of GM-CSF, TNF-a,I L - 1 2 p 7 0a n d
IL-1b in these HFC-mice. Serum amyloid A (SAA) levels
were variable at 6 and 16 weeks post-HFC but were sig-
n i f i c a n t l ye l e v a t e di nt h eH F C - f e dm i c ea t2 6w e e k s
post-HFC. IL-10 levels were increased in the serum of
the HFC-fed mice at 16 weeks but were highly variable.
At 26 weeks, IL-10 levels were more consistently ele-
vated over the chow-fed controls. These measurements
over the course of HFC feeding demonstrated that there
was an inflammatory milieu in these mice.
Histological analysis reveals hepatic steatosis and
inflammation in HFC-fed mice
Histological examination with both H&E and oil red O
staining of liver sections from HFC-fed mice demon-
strated a progressive development of steatosis coupled
with inflammation as shown in Figure 2. No macrovesi-
cular steatosis was observed in livers from chow-fed
mice at 6 and 16 weeks (Figure 2, A-B for H&E and
2G-H for oil red O). Low grade macrovesicular steatosis
was observed in the chow-fed group only at week 26
(Figure 2C for H&E and 2I for oil red O). In contrast to
the chow-fed group, macrovesicular steatosis was
observed in HFC liver as early as 6 weeks after exposure
to HFC diet. At this time point, the fat droplets were
d i s t r i b u t e di nz o n e2a n d3w i t ht h em a j o r i t yi nt h e
intermediate zone (zone 2) between portal and central
veins as shown on H&E stained section (Figure 2D) and
this observation was further confirmed with oil red O
staining (Figure 2J). No cytoplasmic foamy changes were
f o u n da tt h i st i m e .T h en u m b e ra n dt h es i z eo ff a td r o -
plets were dramatically increased by week 16 and 26 as
evident from sections stained with oil-red O (Figure 2,
E-F for H&E and 2K-L for oil red O). In addition to
steatosis, signs of inflammation including infiltration of
inflammatory cells (see insert of Figure 2E) and focal
fibrosis, revealed by trichrome stain (Figure 2M and 2N)
were readily observed in the HFC liver at 16-26 weeks
post-HFC.
Gene expression profiling reveals profound inflammatory
gene regulation specifically in adipose and liver tissues of
HFC-fed mice
To study the molecular mechanisms and pathways
underlying chronic inflammation and insulin resistance,
we utilized a custom-designed gene card to perform
Taqman Low Density Array (TLDA) with multiple tis-
sues taken from HFC- and chow-fed mice. We used
previous comparisons to validate the results from TLDA
by conventional quantitative real-time RT-PCR which
then allowed us to choose TLDA as a high throughput
assay for multiple gene expression profiling throughout
this study. The gene card contains 92 unique genes cho-
sen from their known functions associated with macro-
phages, adipokines, cytokines, chemokines, insulin
signalling, endoplasmic reticulum stress, and glucose,
lipid and energy metabolism (see Additional File 1 for
details). The overall gene expression profiling reveals
profound gene regulation in epididymal adipose tissue,
mesenteric adipose tissue and liver (summarized in
Additional File 2). There was either minor or no change
of these genes in blood cells, muscle, pancreas, spleen
and lymph nodes, based mostly on the results from
pooled RNA samples (see Additional File 3). Our gene
expression profiles in adipose and liver tissues estab-
lished that there is a definitive presence of macrophage
infiltration and inflammatory signals that is induced by
obesity in HFC-fed mice. Here, we describe differential
regulation of several groups of important genes involved
in chronic inflammation and insulin resistance in adi-
pose (epididymal and mesenteric fat pads) and liver
tissues.
mRNA levels of genes involved in macrophage
recruitment are strongly upregulated early in adipose
tissues and progressively switched to liver of HFC- fed
mice
mRNA levels of genes involved in macrophage recruit-
ment including inflammatory chemokines (CCL2, CCL7,
CCL8), chemokine receptor (CCR2) and adhesion mole-
cules (ICAM1, VCAM1), were upregulated in epididy-
mal (EF) adipose tissues at 6 weeks of HFC feeding
(Figure 3). In contrast, in mesenteric (MF) adipose tissue
at this time period, only the mRNA levels of genes cod-
ing for CCR2, ICAM1, VCAM1 were upregulated but
not those of the chemokines. This differential upregula-
tion may provide the early inflammatory signal for
recruiting circulating monocytes into the adipose tissues
of different areas. At this time point, there was no sig-
nificant change in expression of these genes in liver.
The strong upregulation of mRNA levels of these genes
in adipose tissues at 6 weeks was mostly decreased when
the duration of HFC feeding increased to 16 weeks and
26 weeks. The dramatic decrease of relative mRNA level
(fold change) at 16 weeks resulted from a decrease of
mRNA levels in the HFC group and a concomitant
increase of mRNA levels in the chow group. Intriguingly,
mRNA levels of these genes were highly upregulated in
liver at 16 weeks and even further increased at 26 weeks
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Figure 2 Steatosis, inflammation and fibrosis in livers of HFC-fed mice. Liver sections from 6 (A, D, G, J), 16 (B, E, H, K, M, N) and 26 (C, F, I,
L) weeks of chow (A-C, G-I, M) and HFC (D-F, J-L, N) fed mice were analyzed histologically. A-F, H&E stain. Cellular infiltrates are readily seen
throughout 16 and 26 weeks of HFC livers and is illustrated in the insert of E. G-L, Oil red O stain. Increased focal fibrosis as demonstrated by
trichrome stain was found in livers of some HFC-fed mice at 16 weeks (N) or later as compared to 16 week chow-fed liver (M). A-L bar = 0.15
mm. M&N, bar = 0.075 mm.
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nificant gene regulation in the liver of these obese mice.
HFC diet induces macrophage infiltration and
accumulation in adipose and liver tissues
To investigate macrophage infiltration and accumulation
following exposure to HFC diet, gene expression profiles
of several macrophage markers and proteases were eval-
u a t e d .A ss h o w ni nF i g u r e4 ,m R N Al e v e l so ff o u r
macrophage markers CD11c, CD11b, CD68 and F4/80,
were highly upregulated in HFC adipose tissue at all
time points analyzed as compared to chow-fed mice and
peaked at 16 weeks of HFC feeding (Figure 4A).
Another macrophage marker CD83 was upregulated in
a similar manner (See Additional File 2). Two proteases
(MMP12 and CTSS) known to be highly expressed in
macrophages also had a similar gene expression profile
as those macrophage markers (Figure 4B). Again,
significant upregulation of these macrophage markers in
liver was delayed until 16 weeks of HFC feeding.
To confirm increased macrophage accumulation in the
liver we performed IHC with anti-CD11b and anti-
CD11c antibodies (Figure 5). Occasionally, small groups
of CD11b
+ or CD11c
+ aggregates were observed among
the groups of extramedullary hematopoietic (EMH) cells
(Figure 5A and 5B). Consistent with findings by RT-
PCR, no significant increase of CD11b
+ or CD11c
+ cells
were found in livers from chow-fed groups at all time
points (data of later time points not shown) or at
6 weeks post-HFC as compared to chow controls
(Figure 5). However, at 16 and 26 weeks post-HFC, a
significant increase in inflammatory cell numbers was
found in the liver sections of the HFC mice. In addition
to the increased numbers of cells at these time points,
these cells also appeared to be enlarged and demon-
strated a morphology suggesting an activated state,
Figure 3 Genes involved in macrophage recruitment are differentially upregulated in adipose and liver tissues of HFC-fed mice.E F
stands for epididymal fat pad and MF for mesenteric fat pad. Data are presented as fold change of mRNA levels in HFC group vs. chow group.
Statistical significance was determined by two-tailed Welch t test where P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) (details in Methods).
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mRNA. Macrophage infiltration into adipose tissues was
also investigated throughout the same time course. Con-
sistent to TLDA data, in the epididymal fat (EF) macro-
phage infiltrates peaked at week 16 and declined at
week 26 post-HFC (Figure 5I-K). Occasionally, focal
massive infiltrates of CD11b
+ or CD11c
+ cells were also
observed in both 16- and 26-week HFC livers (Figure 5L
and 5M). These two populations of cells appear to co-
exist in the same area as demonstrated by the use of
adjacent sections.
mRNA levels of pro-inflammatory cytokine genes are
differentially upregulated in both adipose and liver
tissues of HFC-fed mice
A complex regulation of pro-inflammatory cytokine
genes was observed at different time points in both adi-
pose and liver tissues, underlying both disease-promoting
and compensatory mechanisms (Figure 6 and 7). As an
example, we determined that the mRNA level of IL-1b
increased throughout the time course in both adipose tis-
sues (EF and MF), as shown by both decrease in ΔCt
(increase in expression level) and increase in fold change
(A)
(B)
Figure 4 Strong upregulation of mRNA levels of macrophage markers and proteases provides a direct evidence for macrophage
infiltration. (A) macrophage markers and (B) proteases. EF stands for epididymal fat pad and MF for mesenteric fat pad. Data are presented as
fold change of mRNA levels in HFC group vs. chow group. Statistical significance was determined by two-tailed Welch t test where P < 0.05 (*),
P < 0.01 (**), and P < 0.001 (***) (details in Methods).
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Figure 5 Macrophage infiltration in HFC-fed liver and adipose tissues. Liver (A-H, L&M) and epididymal fat (I-K) tissues from 6 week chow-
fed (A, E), 6 week HFC-fed (B, F, I), 16 week HFC-fed (C, G, J, L, M) and 26 week HFC-fed (D, H, K) mice were analyzed with
immunohistochemistry using anti-CD11b (A-D), anti-CD11c (E-H) and anti-F4/80 (I-K). L&M are adjacent sections incubated with either anti-CD11b
(L) or anti-CD11c (M) demonstrating similar patterns of cellular infiltrates in the same area of the sections. Arrows in A&E point to groups of
aggregates associated with EMH. bar = 0.15 mm.
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Page 9 of 14(Figure 6). However, analysis of IL-1 receptor antagonist
(IL1RN) showed that although there was a dramatic
increase at 6 weeks of HFC feeding, this was followed by
a substantial decrease in the expression level of IL1RN at
16 weeks and 26 weeks of HFC feeding. In contrast,
IL-18 was not significantly regulated in the HFC-fed
mice (See Additional File 2). In addition, the relative
mRNA levels of TNF-a,T A C E( F i g u r e6 )a n dT G F b-1
(Figure 7) were upregulated throughout the time course
in both adipose tissues. The relative mRNA levels of
IL-6, IL-10 and IFN-g were consistently elevated in
mesenteric (MF) adipose tissue, rather than in epididymal
(EF) adipose tissue (Figure 7).
In the liver, mRNA levels of IL-1b,I L 1 R N ,T N F - a,
IFN-g and TGFb-1 were highly upregulated at 16 weeks
of HFC feeding and further increased at 26 weeks
Figure 6 IL-1b,I L 1 R N ,T N F - a and TACE genes are differentially upregulated in both adipose and liver tissues of HFC-fed mice.
Expression levels of IL-1b, IL1RN, TNF-a and TACE genes from chow (in black) and HFC (in red) fed mice at each time point are presented as
average ΔCt of all animals in each group (details in Methods). The smaller ΔCt value indicates the higher expression level. EF stands for
epididymal fat pad and MF for mesenteric fat pad. The MF sample of 6 week/Chow and the liver samples of 6 week/Chow and 6 week/HFC had
no signal for IL1RN because of very low expression level. In addition, the fold change of mRNA levels in HFC group vs. chow group is also
presented below the expression level panel for each gene. Statistical significance was determined by two-tailed Welch t test where P < 0.05 (*),
P < 0.01 (**), and P < 0.001 (***).
Stanton et al. Journal of Inflammation 2011, 8:8
http://www.journal-inflammation.com/content/8/1/8
Page 10 of 14(Figure 6 and 7), suggesting the presence of severe
inflammation. To confirm an elevation at the protein
level, we examined the expression of IL-1b in liver by
IHC (Figure 8). In general, there was no significant
IL-1b expression in chow-fed livers, except for occa-
sional small groups of aggregates, as shown in the insert
of Figure 8A. Consistent with its mRNA profile, the
numbers of IL-1b
+ cells increased with time in HFC-fed
animals (Figure 8B) indicating the relevance of IL-1b to
liver inflammation. No significant change of IL-1b
expression was observed throughout the time course in
the livers of the chow-fed animals.
Discussion
Our work on gene activation in the HFC-fed mouse
model is an attempt to accurately predict the sites of
drug intervention and to possibly discover new targets
in the mechanisms leading up to the induction of overt
Figure 7 IL-6, IL-10, IFN-g and TGFb-1 genes are differentially upregulated in both adipose and liver tissues of HFC-fed mice. Expression
levels of IL-6, IL-10, IFN-g and TGFb-1 from chow (in black) and HFC (in red) fed mice at each time point are presented as average ΔCt of all
animals in each group. The smaller ΔCt value indicates the higher expression level. EF stands for epididymal fat pad and MF for mesenteric fat
pad. In addition, the fold change of mRNA levels in HFC group vs. chow group is also presented below the expression level panel for each
gene. Statistical significance was determined by two-tailed Welch t test where P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***).
Stanton et al. Journal of Inflammation 2011, 8:8
http://www.journal-inflammation.com/content/8/1/8
Page 11 of 14NASH disease. This paper describes a kinetic study for
the direct temporal and spatial comparison of gene acti-
vation in a variety of organs as compared to age-
matched chow-fed controls. First, a time dependent,
diet-induced development of liver histopathology remi-
niscent of NASH, including steatosis, fibrosis and
inflammatory infiltrates, was observed in the animal
model used in our study of gene expression. Analysis of
temporal inflammatory gene expression in multiple
organs was carried out by TLDA. The epididymal adi-
pose, mesenteric adipose and liver tissues show defini-
tive time-dependent gene activation. In particular, those
genes representing inflammatory mediators change dra-
matically over time. Gene activation to a various degree
was also observed in other organ systems such as the
blood cells, spleen, lymph nodes, gastrocnemius muscle,
or pancreas but these gene patterns do not appear in
any discernible pattern that would impact the induction
of liver disease.
We report here that gene activation occurs early in
the epididymal adipose with the peak activation at 6
weeks post-HFC. This activity in this particular adipose
tissue is followed by a definitive increase in inflamma-
tory signals in the liver at 16 weeks and 26 weeks post-
HFC feeding. On the contrary, activated genes were
downregulated in the epididymal fat pad at these later
time points. This switch in activation profile from epidi-
dymal adipose tissue to liver as determined by quantita-
tive RT-PCR was corroborated by the finding that there
were significant increases in CD11b
+ or CD11c
+ macro-
phages in the liver at 16 weeks and 26 weeks post-HFC
as well as by an increased accumulation of fatty droplets
in the liver. These “activated macrophages” were not
seen in the 6 week HFC livers when evaluated versus
age-matched chow-fed control mice nor were there as
many fatty droplets at this early time point. This
increase in cellularity in the liver also appears in human
disease. Genes involved in monocyte/macrophage
recruitment are over-expressed in the livers of insulin-
resistant human patients [3] and it is well-established
that macrophages will accumulate both in adipose and
liver under the influence of inflammatory signals
[15,16]. Furthermore, the reduction in gene activation
observed in the epididymal adipose tissues at the later
time point was accompanied by a decreased number of
macrophages in this fat pad at 26 weeks post-HFC.
T h e s ed a t as u g g e s tt h a tat r i g g e rf o ri n d u c t i o no f
inflammation was first set off in the adipose tissue and
then sent out to other organ systems as fat feeding con-
tinued over time. This adipose-initiated signal sets up a
process which results in overt liver disease by 26 weeks.
TLDA results of the mesenteric adipose tissue from
HFC-fed mice indicate that inflammatory mediators and
cell activation signals are also induced in this fat depot.
This adipose tissue, however, does not appear to shift as
dramatically in gene activation profile as that of the epi-
didymal fat pad. This continual generation of cytokine
and mediator gene signals found within the mesenteric
fat amplifies the shift toward enhanced gene activation
of the liver in these HFC-fed mice. It has been reported
that the omental fat pad in obese humans can serve as a
steady-state generator of inflammatory mediators which
will then impact the development of disease [17].
Within the panel of genes included in our analysis,
which ranges from metabolic to cellular markers to
inflammatory mediators, IL-1b is identified as one of
the most relevant inflammatory mediator as the disease
induction process shifts from the inflamed epididymal
adipose tissue to the liver. This enhanced IL-1 signal is
relevant to current research findings in human meta-
bolic disease. In obese patients, mRNA levels of IL-1
receptor antagonist (IL-1Ra) and IL-1 receptor type 1
(IL-1R1) are markedly upregulated in white adipose
tissue. In addition, IL-1b gene expression was selec-
tively increased in the visceral fat (but not subcuta-
neous fat) from obese subjects [18]. In patients with
AB
Figure 8 Increased number of IL-1b
+ cells in the liver of HFC-fed mice. Immunohistochemistry of anti-IL-1b demonstrated increased
number of IL-1b
+ cells in HFC-fed liver at 16 weeks (B) as compared to 16 week chow-fed liver (A). Occasionally, small groups of IL-1b
+
aggregates were also detected in chow-fed livers at all time points (insert of A, 6 week chow-fed). bar = 0.075 mm.
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Page 12 of 14type 2 diabetes, the use of Anakinra (IL-1Ra) improved
glycemia and beta-cell secretory function and reduced
markers of systemic inflammation (CRP, IL-6) [19].
Recent positive clinical results from a small trial with
high affinity anti-human IL-1b (XOMA 052) also sup-
port targeting IL-1b mediated inflammatory damage to
pancreatic beta cells as a potential therapeutic
approach for type 2 diabetes [20]. The use of TLDA
technology applied to this mouse model can reveal
further activated or dysregulated gene signals that will
be relevant to human disease.
Excessive pro-inflammatory stimulation enhances the
development of steatosis and NASH. In patients with
acute and chronic liver diseases, production of IL-1
alters as the liver disease shifts in intensity from acute
to chronic cirrhosis [21]. At present, it appears that a
certain mix of cytokines plus a genetic predisposition to
hepatic immune defects may be needed to facilitate pro-
gression of NASH to cirrhosis [22]. Our work demon-
strates that there is very strong and relevant cross-talk
between organ systems of the adipose tissue and the
liver in our HFC mouse model which is also dependent
upon the genotype of the mouse [23]. Use of the TLDA
technology to track gene changes over a time line will
help to unravel some of this immune conversation and
to identify whether new therapeutics can make these
gene signals quiescent.
Conclusions
In the present study, we utilized the mouse model with
a diet containing 45% fat and 0.12% cholesterol (as
found in the Western diet) to investigate the molecular
signals that trigger insulin resistance, hyperinsulinemia
and progression to liver steatosis and fibrosis in the
diet-induced obesity (DIO) mouse model. We used a
sensitive and high throughput technology, Taqman Low
Density Array (TLDA), to study gene expression profil-
ing of 92 important genes representing macrophage-
associated, inflammation-related and metabolism-driven
genes in multiple tissues at 6 weeks, 16 weeks and
26 weeks post high fat and cholesterol (HFC) feeding.
We demonstrate from our analysis of the gene activa-
tion profiles that macrophage infiltration accompanied
by severe inflammation and metabolic changes occurs in
both adipose and liver tissues with a temporal shift in
the levels of these signals depending upon the duration
of HFC feeding. This gene activation initiates early at
6 weeks post-HFC feeding in epididymal adipose tissues.
Activation signals then switch to the liver at 16 and
26 weeks post-HFC feeding. These findings of time
dependent development of steatosis in the liver are sup-
ported by immunohistochemistry. Taken together, the
evidences of gene expression profile, elevated serum ala-
nine aminotransferase, increased liver to body weight
ratio, and histological data support a progression driven
by diet-induced inflammation towards nonalcoholic fatty
liver disease and even nonalcoholic steatohepatitis in
these HFC-fed mice within the time frame of 26 weeks.
Additional material
Additional file 1: Table S1. The table shows a list of 92 genes designed
on the gene card for Taqman Low Density Array. Table S1. The gene
panel for gene expression study by Taqman Low Density Array
Additional file 2: Table S2, S3, and S4. High fat and cholesterol diet
(HFC) induced gene regulation in epididymal adipose tissues, mesenteric
adipose tissues and liver of C57BL/6 mice. These tables contain the gene
expression profile of all genes in this study. Table S2. The gene
expression profile in epididymal adipose tissues of HFC-fed mice Table
S3. The gene expression profile in mesenteric adipose tissues of HFC-
fed mice. Table S4. The gene expression profile in liver of HFC-fed mice
Additional file 3: Table S5 and S6. High fat and cholesterol diet (HFC)
induced gene regulation in blood cell, muscle, spleen, lymph node and
pancreas tissues of C57BL/6 mice. These tables contain the gene
expression profile of all genes in this study, mostly from pooled RNAs
without statistical analyses. Table S5. The gene expression profile in
blood cells, muscle and spleen tissues. Table S6. The gene expression
profile in lymph node and pancreas tissues
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